An international clinical trial has found a way to minimise the risk of tumour recurrence in bowel cancer patients to as little as one per cent.
Canadian researchers have shown that the targeted cancer drug olaparib can also reduce the size of tumours in a substantial minority of ovarian cancer patients.
Cancer Research UK and Cancer Research Technology have reached an agreement with AstraZeneca to take compound AZD-3965, a first-of-its-kind experimental drug to...
Long-term use of low-dose aspirin could reduce the number of cases of bowel cancer and deaths from the disease, British scientists have found.
A powerful new cancer drug discovery database has been launched to speed up the process of bringing drugs from 'bench to bedside'.
Nearly two-fifths of breast cancers change form when they spread to the lymph nodes in the armpit, UK scientists have found.